Trials / Completed
CompletedNCT00960986
A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder
A Phase 4 Comparison of Duloxetine Dosing Strategies in the Treatment of Korean Patients With Major Depressive Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 249 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess nausea severity in response to four different drug dosing strategies of Duloxetine (30 mg with food, 60 mg with food, 30 mg without food, and 60 mg without food) in Korean patients with major depressive disorder (MDD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine hydrochloride | po, QD |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-02-01
- Completion
- 2011-04-01
- First posted
- 2009-08-18
- Last updated
- 2014-12-31
- Results posted
- 2012-04-17
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00960986. Inclusion in this directory is not an endorsement.